A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

Clinical trial NCT03080311 · COMPLETED

Trial details

NCT number: NCT03080311
Sponsor: Ascentage Pharma Group Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Solid Tumor

Start date: 2017-02-12
Primary completion: 2020-06-22
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.